LOXL2 and ovarian serous cystadenocarcinoma: However, four (LOX, LOXL1, LOXL2, LOXL4) and three (LOX, LOXL1, LOXL4) members were present in the mesothelioma (MESO; 87 patients, 239 genes) and ovarian serous cystadenocarcinoma (OV; 427 patients, 209 genes) datasets.